Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line

International Journal of Clinical and Laboratory Research

Volumn 29, Issue 4, 1999, Pages 135-140

  Pedrinaci, S ^a   Algarra, I ^b   Garrido, F ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

Author keywords

Cytotoxicity; Natural killer cells; NKL cell line; PSK

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; CD94 ANTIGEN; INTERLEUKIN 2; KLRD1 PROTEIN, HUMAN; KRESTIN; LECTIN; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PROTEOGLYCAN; PS-K;

ARTICLE; BIOSYNTHESIS; CELL STRAIN K 562; CELL STRAIN U937; CELL SURVIVAL; CYTOLOGY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; METABOLISM; NATURAL KILLER CELL; PHYSIOLOGY;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD94; ANTIGENS, SURFACE; BIOLOGICAL RESPONSE MODIFIERS; CELL SURVIVAL; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; K562 CELLS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; PROTEOGLYCANS; U937 CELLS;

EID: 0033497834     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005990050079     Document Type: Article

References (20)

1. Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K. Krestin (PSK). Cancer Treat Rev 1984;11:131.
2. Ogoshi K, Satou H, Isono K, Mitomi T, Endoch M, Suaita M. Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study. Cancer Invest 1995;13:363.
3. Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet 1994; 343:1122.
4. Yefenof E, Einat E, Klein E. Potentiation of T cell immunity against radiation-leukemia-virus-induced lymphoma by polysaccharide K. Cancer Immunol Immunother 1991;34:133.
5. Nio Y, Shiraishi T, Tsubono M, Morimoto H, Tseng CC. Imai S, Tobe T. In vitro immunomodulating effect of protein-bound polysaccharide, PSK on peripheral blood. regional nodes, and spleen lymphocytes in patients with gastric cancer. Cancer Immunol Immunother 1991;32:335.
6. Kobayashi H, Matsunaga K, Fujii M. PSK as a chemopreventive agent. Cancer Epidemiol Biomarkers Prev 1993;2:271.
7. Kariya Y, Inoue N, Kihara T, Okamoto N, Sugie K, Mori T, Uchida A. Activation of human natural killer cells by the protein bound polysaccharide PSK independently of Interferon and interleukin 2. Immunol Lett 1992;31:241.
8. Algarra I, Collado A, Garrido F. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones. J Exp Clin Cancer Res 1997;16:373.
9. Algarra I, Garcia A, Collado A, Garrido F. Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors. J Exp Clin Cancer Res 1999;18,1:39.
10. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 1996;24:406.
11. Samaradis J, Colonna M, Cloning of novel immunoglobulin superfamily receptors expressed on myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol 1996;27:660.
12. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samarandis J, Angman L, Cella M, Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I on human Iymphoid and myelomonocytic cells. J Exp Med 1997;186:1809.
13. Robertson MJ, Cochran KJ, Ritz J. Characterization of surface antigens expressed by normal and neoplastic human natural killer cells. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein RL, Springer TA, Tedder TF, Todd RF, eds. Leukocyte typing V, White differentiation antigens. Oxford: Oxford Press 1995: 1374.
14. Nakarai T, Robertson MJ, Streuli M, Wu Z, Ciardelli TL, Smith KA, Ritz J. Interleukin 2 receptor γ chain expression on restins and activated lymphoid cells. J Exp Med 1994;180: 241.
15. Carretero M, Cantoni C, Bellon T, Bottino C, Biassoni R, Rodrigues A, Perez-Villar JJ, Moretta L, Moretta A, Lopez-Botet M. The CD94 and NKG2-A C type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol 1997;27:563.
16. Perez-Villar JJ, Melero I, Navarro F, Carretero M, Bellon T, Llano M, Colonna M, Geraghty DE, Lopet-Botet M. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol 1997;158:5736.
17. Pessino A, Sivore S, Bottino C, Malaspina A, Morelli L, Moretta L, Biassoni R, Moretta A, Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 1998;188:953.
18. Sivori S, Pende D, Bottino C, Marcenaro E, Pessino A, Biassoni R, Moretta L, Moretta A. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol 1999;29:1656.
19. Cantoni C, Bottino C, Vitale M, Pessiono A, Augugliaro R, Malaspina A, Parolini S, Moretta L, Moretta A, Biassoni R. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 1999;189:787.
20. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T. Activation of NK cells and T cells by NKG2D. a receptor for stress-inducible MICA. Science 1999;285:727.